Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients

Critical Care Medicine

Volumn 25, Issue 5, 1997, Pages 795-800

  Bacher, Andreas ^a,b   Mayer, Nikolaus ^a   Klimscha, Walter ^a   Oismüller, Christiane ^a   Steltzer, Heinz ^a   Hammerle, Alfons ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cardiac output; Catheterization, pulmonary artery; Critical illness; Hemodynamics; oxygen; Pentoxifylline; Phosphodiesterase inhibitor; Sepals; Thermodilution technique; Transport, uptake

Indexed keywords

DOBUTAMINE; DOPAMINE; NORADRENALIN; PENTOXIFYLLINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFECT; FEMALE; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; MALE; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; SEPSIS; THERMODILUTION; TISSUE OXYGENATION;

ADULT; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; SEPSIS; THERMODILUTION; VASODILATOR AGENTS;

EID: 0030997420     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199705000-00014     Document Type: Article

References (35)

1. Shoemaker WC, Appel PL, Kram HB: Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988; 16: 1117-1120
2. Hankeln KB, Gronemeyer R, Held A, et al: Use of continuous noninvasive measurement of oxygen consumption in patients with adult respiratory distress syndrome following shock of various etiologies. Crit Care Med 1991; 19: 642-649
3. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032
4. Thiel M, Bardenheuer H, Pöch G, et al: Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 180:53-58
5. Currie MS, Rao KMK, Padmanabhan J, et al: Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J Leukoc Biol 1990; 47: 244-250
6. Zheng H, Crowley J, Chan JC, et al: Attenuation of LPS induced neutrophil thromboxane B2 release and chemiluminescence. J Cell Physiol 1991; 146: 264-269
7. 2) by pentoxifylline from human vascular tissue. Arzneimittelforschung 1982; 32: 1315-1318
8. Han BJ, Thompson B, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at seperate points in the signaling pathway. J Exp Med 1990; 172:391-394
9. Schandene L, Vandenbussche P, Crusiaux A: Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) by monocytes and T cells. Immunology 1992; 76:30-34
10. Waxman K, Clark L, Soliman MH, et al: Pentoxifylline in resuscitation of experimental hemorrhagic shock. Crit Care Med 1991; 19:728-731
11. Tighe D, Moss R, Hynd J, et al: Pretreatment with pentoxifylline improves the hemodynamic and histologic changes and decreases neutrophil adhesiveness in a pig fecal peritonitis model. Crit Care Med 1990; 18:184-189
12. Gorbatschova FE, Turaschwili GA, Kvassov VT, et al: The circulatory and clinical effects of pentoxifylline. Pharmatherapeutica 1978; 2:100-104
13. Heidrich H, Paeprer M, Barckow D, et al: The effect of pentoxifylline on central and peripheral haemodynamics - An experimental clinical study. Z Kardiol 1976; 65:385-391
14. Montravers P, Fagon JY, Gilbert C, et al: Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest 1993; 103: 1017-1022
15. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis Chest 1992; 101:1644-1655
16. Yeung HC, Lu MW, Martinez EG, et al: Critical care scoring system - New concept based on hemodynamic data. Crit Care Med 1990; 18:1347-1352
17. Stratton HH, Feustel PJ, Newell JC: Regression of calculated variables in the presence of a shared measurement error. J Appl Physiol 1987; 62:2083-2093
18. Porembka DT: Cardiovascular abnormalities in sepsis. New Horiz 1993; 1: 324-341
19. Jardin F, Brun-Ney D, Auvert B, et al: Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055-1060
20. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113: 227-242
21. Ognibene FP, Parker MM, Natanson C, et al: Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93:903-910
22. Oismüller C, Mayer N, Micksche M, et al: In vivo modulation of human neutrophil function by pentoxifylline in patients with septic syndrome. Shock 1995; 4:161-165
23. McDonald R: Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am Rev Respir Dis 1991; 144:1347-1350
24. Williams JH, Heshmati S, Tamadon S, et al: Inhibition of alveolar macrophages by pentoxifylline. Crit Care Med 1991; 19:1073-1078
25. Lilly CM, Sandhu JS, Ishizaka A, et al: Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 1989; 139:1361-1368
26. Chalkiadakis GE, Kostakis A, Karayannacos PE, et al: Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg 1985; 120: 1141-1144
27. Berens KL, Langston JD, Wasan KM, et al: Influence of pentoxifylline and related analogues in endotoxemic renal failure. Circ Shock 1991; 34:344-348
28. Flammand FJ, Sibbald WJ, Girotti MJ, et al: Pentoxifylline does not prevent microvascular injury in normotensive, septic rats. Crit Care Med 1995; 23: 119-124
29. 2+ accumulation and transglutaminase activation in rat erythrocytes. J Clin Pharmacol 1991; 31:531-536
30. Smud R, Sermukslis B, Kartin D: Changes in blood viscosity induced by pentoxifylline. Pharmatherapeutica 1976; 1:229-233
31. Flynn WJ, Cryer HG, Garrison RN: Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 1991; 110:350-356
32. Ridings PC, Windsor AC, Sugerman HJ, et al: Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established. Arch Surg 1994; 129: 1144-1152
33. Martich GD, Parker MM, Cunnion RE, et al: Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin. J Appl Physiol 1992; 73:925-931
34. Oropello JM, Amin D, Klapholtz A, et al: Effects of pentoxifylline on hemodynamics, oxygen transport, and tissue metabolism in experimental, severe hemorrhagic shock. Crit Care Med 1991; 19:1540-1544
35. Hershenson MB, Schena JA, Lozano PA, et al: Effect of pentoxifylline on oxygen transport during hypothermia. J Appl Physiol 1989; 66:96-101